Harbor-UCLA Medical Center
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Harbor-UCLA Medical Center
Derived from Strategic Transactions, a fully searchable premium source for tracking life sciences deal activity, the Tech Transfer Deals column provides a monthly update on technology transfer deals, reporting licensing agreements between companies and universities or other research institutions within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced May through June 2014.
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions
Much of the innovation in cosmetic dermatology has come from the multibillion-dollar, largely unregulated cosmeceuticals industry. But Kythera Biopharmaceuticals aims to bring true, rigorous clinical science to the field, with prescription drugs that modulate novel biological pathways in aesthetic and restorative indications.
- Academic and Research Institutions
- Hospitals, Nursing Homes, Institutions